The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Acute Ischemic Stroke Therapeutics Market Research Report 2024
Synopsis
AIS is a chronic condition characterized by the sudden loss of blood supply to a part of the brain, thus causing subsequent loss of neurological function. AIS is caused by thrombotic or embolic obstruction of the cerebral artery and is more common than hemorrhagic stroke. The global AIS therapeutics market is expected to register a low single digit market growth during the forecast period. The marginal growth rate is attributed to the lack of approved drugs in this area, the presence of alternative therapies, extensive use of generics, and unmet needs for anticoagulant reversal agents.
The global Acute Ischemic Stroke Therapeutics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Technavio's analysts forecast the global acute ischemic stroke therapeutics market to grow at a CAGR of 2.11% during the period 2017-2025.
This report aims to provide a comprehensive presentation of the global market for Acute Ischemic Stroke Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Acute Ischemic Stroke Therapeutics.
Report Scope
The Acute Ischemic Stroke Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Acute Ischemic Stroke Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Acute Ischemic Stroke Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer
Boehringer Ingelheim
Roche
Sanofi
Biogen
Daiichi Sankyo
Pfizer
Segment by Type
Thrombolytic Therapeutics
Antihypertensive Therapeutics
Antiplatelet Therapeutics
Anticoagulants
Segment by Application
Hospitals
Ambulatory Surgical Center
Diagnostic Centers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Acute Ischemic Stroke Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
AIS is a chronic condition characterized by the sudden loss of blood supply to a part of the brain, thus causing subsequent loss of neurological function. AIS is caused by thrombotic or embolic obstruction of the cerebral artery and is more common than hemorrhagic stroke. The global AIS therapeutics market is expected to register a low single digit market growth during the forecast period. The marginal growth rate is attributed to the lack of approved drugs in this area, the presence of alternative therapies, extensive use of generics, and unmet needs for anticoagulant reversal agents.
The global Acute Ischemic Stroke Therapeutics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Technavio's analysts forecast the global acute ischemic stroke therapeutics market to grow at a CAGR of 2.11% during the period 2017-2025.
This report aims to provide a comprehensive presentation of the global market for Acute Ischemic Stroke Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Acute Ischemic Stroke Therapeutics.
Report Scope
The Acute Ischemic Stroke Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Acute Ischemic Stroke Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Acute Ischemic Stroke Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer
Boehringer Ingelheim
Roche
Sanofi
Biogen
Daiichi Sankyo
Pfizer
Segment by Type
Thrombolytic Therapeutics
Antihypertensive Therapeutics
Antiplatelet Therapeutics
Anticoagulants
Segment by Application
Hospitals
Ambulatory Surgical Center
Diagnostic Centers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Acute Ischemic Stroke Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Acute Ischemic Stroke Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Thrombolytic Therapeutics
1.2.3 Antihypertensive Therapeutics
1.2.4 Antiplatelet Therapeutics
1.2.5 Anticoagulants
1.3 Market by Application
1.3.1 Global Acute Ischemic Stroke Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Center
1.3.4 Diagnostic Centers
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Acute Ischemic Stroke Therapeutics Market Perspective (2019-2030)
2.2 Acute Ischemic Stroke Therapeutics Growth Trends by Region
2.2.1 Global Acute Ischemic Stroke Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Acute Ischemic Stroke Therapeutics Historic Market Size by Region (2019-2024)
2.2.3 Acute Ischemic Stroke Therapeutics Forecasted Market Size by Region (2025-2030)
2.3 Acute Ischemic Stroke Therapeutics Market Dynamics
2.3.1 Acute Ischemic Stroke Therapeutics Industry Trends
2.3.2 Acute Ischemic Stroke Therapeutics Market Drivers
2.3.3 Acute Ischemic Stroke Therapeutics Market Challenges
2.3.4 Acute Ischemic Stroke Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Acute Ischemic Stroke Therapeutics Players by Revenue
3.1.1 Global Top Acute Ischemic Stroke Therapeutics Players by Revenue (2019-2024)
3.1.2 Global Acute Ischemic Stroke Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Acute Ischemic Stroke Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Acute Ischemic Stroke Therapeutics Revenue
3.4 Global Acute Ischemic Stroke Therapeutics Market Concentration Ratio
3.4.1 Global Acute Ischemic Stroke Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Acute Ischemic Stroke Therapeutics Revenue in 2023
3.5 Acute Ischemic Stroke Therapeutics Key Players Head office and Area Served
3.6 Key Players Acute Ischemic Stroke Therapeutics Product Solution and Service
3.7 Date of Enter into Acute Ischemic Stroke Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Acute Ischemic Stroke Therapeutics Breakdown Data by Type
4.1 Global Acute Ischemic Stroke Therapeutics Historic Market Size by Type (2019-2024)
4.2 Global Acute Ischemic Stroke Therapeutics Forecasted Market Size by Type (2025-2030)
5 Acute Ischemic Stroke Therapeutics Breakdown Data by Application
5.1 Global Acute Ischemic Stroke Therapeutics Historic Market Size by Application (2019-2024)
5.2 Global Acute Ischemic Stroke Therapeutics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Acute Ischemic Stroke Therapeutics Market Size (2019-2030)
6.2 North America Acute Ischemic Stroke Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Acute Ischemic Stroke Therapeutics Market Size by Country (2019-2024)
6.4 North America Acute Ischemic Stroke Therapeutics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Acute Ischemic Stroke Therapeutics Market Size (2019-2030)
7.2 Europe Acute Ischemic Stroke Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Acute Ischemic Stroke Therapeutics Market Size by Country (2019-2024)
7.4 Europe Acute Ischemic Stroke Therapeutics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Acute Ischemic Stroke Therapeutics Market Size (2019-2030)
8.2 Asia-Pacific Acute Ischemic Stroke Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Acute Ischemic Stroke Therapeutics Market Size by Region (2019-2024)
8.4 Asia-Pacific Acute Ischemic Stroke Therapeutics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Acute Ischemic Stroke Therapeutics Market Size (2019-2030)
9.2 Latin America Acute Ischemic Stroke Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Acute Ischemic Stroke Therapeutics Market Size by Country (2019-2024)
9.4 Latin America Acute Ischemic Stroke Therapeutics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Acute Ischemic Stroke Therapeutics Market Size (2019-2030)
10.2 Middle East & Africa Acute Ischemic Stroke Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Acute Ischemic Stroke Therapeutics Market Size by Country (2019-2024)
10.4 Middle East & Africa Acute Ischemic Stroke Therapeutics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bayer
11.1.1 Bayer Company Detail
11.1.2 Bayer Business Overview
11.1.3 Bayer Acute Ischemic Stroke Therapeutics Introduction
11.1.4 Bayer Revenue in Acute Ischemic Stroke Therapeutics Business (2019-2024)
11.1.5 Bayer Recent Development
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Company Detail
11.2.2 Boehringer Ingelheim Business Overview
11.2.3 Boehringer Ingelheim Acute Ischemic Stroke Therapeutics Introduction
11.2.4 Boehringer Ingelheim Revenue in Acute Ischemic Stroke Therapeutics Business (2019-2024)
11.2.5 Boehringer Ingelheim Recent Development
11.3 Roche
11.3.1 Roche Company Detail
11.3.2 Roche Business Overview
11.3.3 Roche Acute Ischemic Stroke Therapeutics Introduction
11.3.4 Roche Revenue in Acute Ischemic Stroke Therapeutics Business (2019-2024)
11.3.5 Roche Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Detail
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Acute Ischemic Stroke Therapeutics Introduction
11.4.4 Sanofi Revenue in Acute Ischemic Stroke Therapeutics Business (2019-2024)
11.4.5 Sanofi Recent Development
11.5 Biogen
11.5.1 Biogen Company Detail
11.5.2 Biogen Business Overview
11.5.3 Biogen Acute Ischemic Stroke Therapeutics Introduction
11.5.4 Biogen Revenue in Acute Ischemic Stroke Therapeutics Business (2019-2024)
11.5.5 Biogen Recent Development
11.6 Daiichi Sankyo
11.6.1 Daiichi Sankyo Company Detail
11.6.2 Daiichi Sankyo Business Overview
11.6.3 Daiichi Sankyo Acute Ischemic Stroke Therapeutics Introduction
11.6.4 Daiichi Sankyo Revenue in Acute Ischemic Stroke Therapeutics Business (2019-2024)
11.6.5 Daiichi Sankyo Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Detail
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Acute Ischemic Stroke Therapeutics Introduction
11.7.4 Pfizer Revenue in Acute Ischemic Stroke Therapeutics Business (2019-2024)
11.7.5 Pfizer Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
